首页> 外文期刊>National Journal of Community Medicine >A Study of Extended Spectrum ?-Lactamase (ESBL) and AmpC ?-Lactamase Producing Klebsiella Pneumoniae in Neonatal Intensive Care Unit at Tertiary Care Hospital, Ahmedabad
【24h】

A Study of Extended Spectrum ?-Lactamase (ESBL) and AmpC ?-Lactamase Producing Klebsiella Pneumoniae in Neonatal Intensive Care Unit at Tertiary Care Hospital, Ahmedabad

机译:艾哈迈达巴德三级护理医院新生儿重症监护病房产生超广谱β-内酰胺酶(ESBL)和AmpCβ-内酰胺酶生产肺炎克雷伯菌的研究

获取原文
       

摘要

Background & objectives: Clinical laboratories need to develop quick screening methods for detection of Extended Spectrum ?-Lactamases (ESBL) & Amplified C (AmpC) ?-Lactamase, so that the appropriate medication can be started without delay. Here, we reported the screening & confirmatory methods for detection of ESBL & AmpC in Klebsiella pneumoniae in Neonatal Intensive Care Unit (NICU). Methods: We had tested 600 blood culture samples from the NICU patients. From the positive bacterial isolates, Klebsiella pneumoniae were screened for ESBL & AmpC production followed by confirmatory methods as per Clinical Laboratory Standard Institute (CLSI) guidelines. Results: Out of the 600 blood culture, 266 were positive for microbial growth. Among them, Klebsiella pneumoniae were in 54 patients. Out of 54 Klebsiella pneumoniae, 48 were positive for ESBL in screening method. Out of 48, 41 isolates were ESBL positive & 4 were AmpC positive by Confirmatory test (Modified Three Dimensional Method for AmpC). Interpretation & conclusions: The prevalence of ESBL & AmpC producing Klebsiella pneumoniae in NICU at our institute is 75.92% & 7.4% which is very alarming, and it requires strict implementation of infection control guidelines in NICU by safe hygiene practices, restricted use of broad spectrum antibiotics as empirical therapy in septicemic cases and also formulation of uniform antibiotic policy for such patients based on the current trend of antibiotic resistance. This can be helpful in preventing emergence of multidrug resistance in such organisms.
机译:背景与目的:临床实验室需要开发快速筛选方法来检测超广谱β-内酰胺酶(ESBL)和扩增C(AmpC)β-内酰胺酶,以便可以立即开始使用适当的药物。在这里,我们报道了新生儿重症监护病房(NICU)肺炎克雷伯菌中ESBL和AmpC的筛选和确认方法。方法:我们对NICU患者的600份血液培养样本进行了测试。从阳性细菌分离物中筛选肺炎克雷伯菌的ESBL和AmpC产生,然后按照临床实验室标准协会(CLSI)指南进行确认。结果:在600份血液培养物中,有266份微生物生长呈阳性。其中,肺炎克雷伯菌有54例。在筛选方法中,在54例肺炎克雷伯菌中,有48例ESBL阳性。通过确认试验(改良的AmpC三维方法),在48株菌株中,有41株为ESBL阳性,4株为AmpC阳性。解释与结论:我院新生儿重症监护病房(ESCU)产ESBL和AmpC的肺炎克雷伯菌的患病率分别为75.92%和7.4%,这非常令人震惊,它需要通过安全卫生措施严格限制新生儿重症监护病房的感染控制指南,并限制使用广谱抗生素作为败血症病例的经验疗法,并根据当前抗生素耐药性趋势为此类患者制定统一的抗生素政策。这有助于防止此类生物体出现多药耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号